RadMax Technology Chief Engineer to Participate in UAS West Symposium

Multi-media Productions (USA) and– REGI U.S., Inc. are pleased to announce that Paul Porter , Chief Engineer, for the RadMax™ technology, will be attending the Unmanned Aircraft Systems West Symposium ("UAS") in Washington DC on May 8-9, 2013. Mr. Porter will be a speaker and a presenter at the symposium for the RadMax™ technology on May 8-9, 2013.

The UAS will be focusing on future developments of the UAS, which is estimated for global spending of $71 billion over the next 10 years.

This comprehensive conference brings together key officials and representatives from both the government and industry that will examine the recent developments most critical capability gaps and likely future direction for unmanned aircraft systems.

Paul Porter , chief engineer, states, "This is an excellent opportunity for REGI U.S., Inc. to attract interested end users in the military and aerospace sector, to find out information on our light weight, fuel efficient, RadMax rotary engine."

ABOUT REGI U.S., INC. AND REG TECHNOLOGIES INC.

Reg Technologies Inc. and REGI U.S., Inc. have developed for testing and demonstration an improved axial vane type rotary engine known as the Rand Cam™/RadMax™ rotary technology used in the revolutionary design of lightweight and high efficiency engines, compressors and pumps. The RadMax™ engine has only two unique moving parts, the vanes (up to 12) and the rotor, compared to the 40 moving parts in a simple four-cylinder piston engine. This innovative design makes it possible to produce up to 24 continuous power impulses per one rotation that is vibration-free and extremely quiet. The RadMax™ engine also has multitude capabilities allowing it to operate on fuels including gasoline, natural gas, hydrogen, propane and diesel.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.